Search by Drug Name or NDC

    NDC 47335-0986-83 EZALLOR SPRINKLE 20 mg/1 Details

    EZALLOR SPRINKLE 20 mg/1

    EZALLOR SPRINKLE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is ROSUVASTATIN CALCIUM.

    Product Information

    NDC 47335-0986
    Product ID 47335-986_a0b982dc-e829-436e-88c6-c2e77eac37f0
    Associated GPIs 39400060106820
    GCN Sequence Number 079381
    GCN Sequence Number Description rosuvastatin calcium CAP SPRINK 20 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 40734
    HICL Sequence Number 025009
    HICL Sequence Number Description ROSUVASTATIN CALCIUM
    Brand/Generic Brand
    Proprietary Name EZALLOR SPRINKLE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ROSUVASTATIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name ROSUVASTATIN CALCIUM
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208647
    Listing Certified Through 2024-12-31

    Package

    NDC 47335-0986-83 (47335098683)

    NDC Package Code 47335-986-83
    Billing NDC 47335098683
    Package 30 CAPSULE in 1 BOTTLE (47335-986-83)
    Marketing Start Date 2019-05-04
    NDC Exclude Flag N
    Pricing Information N/A